washington university in st louis division

The Bears have won 23 NCAA Division III Championships two in women's cross country (2011, 2018), one in women's indoor track and field (2017), . COVID-19 Resources; Canvas; St. Louis, MO Washington University (Missouri) Conference . One of the tenets of Washington University School of Medicine is leading the way in innovative research. A small clinical trial conducted by Rizwan Romee and Todd Fehniger provides evidence that the immune systems "natural killer" cells can be dialed up in the laboratory, trained to recall that activation and then effectively unleashed to destroy cancer cells in some patients. Nat Struct Mol Biol 2022 Mar 24, Stuart A. Kornfeld, MD, the David C. and Betty Farrell Distinguished Professor of Medicine at Washington University School of Medicine, has received the 2022 Roscoe O. Brady Award for Innovation and Accomplishment from the WORLDSymposium (WORLD is an acronym for Were Organizing Research on Lysosomal Diseases), a research conference dedicated to lysosomal diseases. Divisions and Sections. His research over the past 25 years has focused on characterizing mechanisms regulating normal and malignant hematopoiesis. Washington University Division of Urology Now Offering Virtual Visits Washington University Urology is committed to helping you manage your health and is now offering virtual patient visits. Twitter The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer. Now, Wang-Sik Lee and Stuart Kornfeld, in collaboration with Huilin Li at the Van Andel Institute, show how this enzyme discriminates between the lysosomal hydrolases and numerous other secreted glycoproteins having identical glycan chains, thereby ensuring that only the former acquire the Man-6-P tag. The grant, from the National Institutes of Health (NIH), funds a prestigious Specialized Program in Research Excellence (SPORE) in leukemia. Human and Statistical Genetics. Email Access WU Record 3/5/18, While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. Kornfeld's research has been instrumental in understanding the workings of lysosomal proteins, which must make their way to the cells' lysosomes in order to digest cellular parts and molecules that are no longer needed and help cells dispose of viruses and bacteria. Washington University in St. Louis was founded in 1853 as a nondenominational community of scholars, and has developed into an independent university known for its excellence in teaching and research and for the quality of its faculty and student body. 2022 Washington University in St. Louis . DSc, Washington University in St. Louis cdgill@wustl.edu Professor Gill's research focuses on assuring properties of distributed real-time and embedded systems in which software complexity, unpredictable environments, and heterogeneous platforms demand novel solutions that are grounded in sound theory. Experience the research, scholarship and creativity that drive us every day. The virus can activate immune cells to destroy glioblastoma cancer cells in mice, giving a powerful boost to an immunotherapy drug (anti-PD-1 antibody) and sparking long-lasting immunological memory that can ward off tumor recurrence for at least 18 months. About the division: Danforth University Center, Suite 200; studentaffairs@wustl.edu; 314-935-4526; Hours: Mon-Fri 8:30 a.m.-5 p.m. 2022 Washington University in St.Louis, 1,500+ courses offered and 90+ fields of study, 77 diversity-related student groups on campus, 567,000 plastic bottles eliminated annually, Graduate, Professional and Advanced Learning, Graduate and Professional School Policies, Intellectual Property and Research Policies. Molecular Cell Biology. Faculty Opportunities. Phone: 314-362-8940 | Fax: 314-362-2505. WU Record 5/10/18, An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Jaebok Choi, John DiPersio and colleagues. WU Record 1/20/21 | Gastroenterology 2021 Jan 20, Jeff Ward and Chris Miller are members of a global consortium that has identified features of tumor neoantigens that trigger T cells to attack the cancer and leave healthy tissue untouched. Participation is initiated through a point-based, self-assessment checklist with which offices can evaluate their current practices, set goals, and be recognized for their sustainable practices. Govindan was honored for his innovative research, including in genomics, aimed at developing better lung cancer therapies and improving patient outcomes. This program includes genetic counseling and screening of family members with a history of prostate cancer. One Children's Place. Length of Program Program Details Educational Goals Case Requirements Eligibility Requirements Licensure Requirements Application Process Contact Us Varun Puri, MD, MSCI 314-362-4191 Professor of Surgery The Washington University Division of Reproductive Endocrinology and Infertility has been a leader in assisted reproductive technologies (ART) from the start. Andrew C. Glatz, MD, has been selected to lead the Division of Pediatric Cardiology in the Department of Pediatrics at Washington University School of Medicine in St. Louis. These "complex indels" appear to cluster in important cancer genes more often than can be attributed to random chance. About St. Louis. Now, a team led by Todd Fehniger has shown in preclinical studies conducted in mice and human cells that this type of cell-based immunotherapy also could be effective against solid tumors, starting with melanoma, a type of skin cancer that can be deadly if not caught early. By taking a deep dive into the genomics and proteomics of lung cancer patients participating in clinical trials, the investigators will seek patterns emerging at the gene and protein levels that could flag a tumor as being likely to return after surgery or chemotherapy. This 18-month, 42 credit hour program is designed to train students as critical thinkers and analysts in the discipline of biostatistics. In a battle of two St. Louis area institutions, Zach Hausner (Jr., Pacific Palisades, Calif.) scored eight goals as Division III No. Tap into latest developments, opportunities and insights from the Division of Gastroenterology, New Patients with Inflammatory Bowel Disease, Gastrointestinal Center Moves to New Clinical Space at Center for Advanced Medicine, Introducing the 10 emerging leaders selected as AGA FORWARD. Public Tour: Katharina Grosse Studio Paintings, Irans Gen Z: The Leadership of Young Women and Girls in the National Uprising. St. Louis, MO 63130-4899. Office Location: 1 Barnes-Jewish Hospital Plaza. 11/Great Lakes Division Champion Washington University in St. Louis exploited 5-3, 5-3 and 6-1 scoring advantages in the first, second and third quarters, respectively, to manage No. At a glance Luis Batista, Chris Sturgeon and co-workers used CRISPR to edit into human embryonic stem cells two mutations associated with the disease to produce a novel model of the disorder. The investigators found that leukemia cells from patients who relapsed after transplant often had greatly reduced expression of genes that were involved with the recognition of cancer cells by the immune system and that interferon gamma could restore expression of these genes. After analyzing the complex metabolism of these tumors, Brian Van Tine, Jason Held, and co-workers discovered that adding a glutamine inhibitor to an arginine-depleting drug killed the cells and caused tumor regression inmice. Timothy J. Ley, MD, the Lewis T. and Rosalind B. Apple Professor of Medicine, has been honored by the American Society of Hematology with the Henry Stratton Medal, awarded annually to one basic scientist and one clinical or translational researcher who have made outstanding contributions to hematology. Today. November 17, 2022 ST. LOUIS Joe knew something was terribly wrong when his wife, an energetic nurse and mother of three, became forgetful in her early 60s. Washington University in St. Louis (WashU, or WUSTL) is a private research university with its main campus in St. Louis County, and Clayton, . WU Record 2/11/21 | Cancer Cell 2021 Feb 2, An innovative approach to treating bone tumors starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects. WU Record 10/31/18, A large genomic analysis led by Obi Griffith in the Division of Oncology and The McDonnell Genome Institute has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer. This approach can be performed when conventional testing methods are unsuccessful and also could be applied to other cancers, including solid tumors. Nature Communications 2018 Sep 4 | WU Record 9/14/18, Using genetic sequencing, scientists have revealed the complete DNA makeup of more than 100 aggressive prostate tumors, pinpointing important genetic errors these deadly tumors have in common. St. Louis Children's Hospital is a Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies. The Department of Surgery is committed to excellence in patient care, cutting-edge research, innovative training programs, and investments in diversity and health equity. He is being recognized for leading the effort to sequence the first human cancer genomes, from patients with acute myeloid leukemia (AML). Science Translational Medicine 2016 Sep 21 | WU Record 9/21/16, The level of an RNA molecule (PCAT-14) expressed in prostate tumors is an indicator of whether the cancer is likely to spread, according to research published by Chris Maher and colleagues. WU Record 9/30/21 | J Clin Oncol 2021 Sep 30, Analysis of DNA in blood and urine (liquid biopsy) could lead to faster and less invasive methods to diagnose and monitor various types of tumors. WU Record 12/1/21 | Sci Transl Med 2021 Dec, Elaine M. Majerus, MD, PhD and Stephen T. Oh, MD, PhD, have been named co-Chiefs of the Division of Hematology in the Department of Medicine, effective December1, 2021. Department of Medicine News, John DiPersio and colleagues have developed a method of stem cell transplantation in mice that does not require radiation or chemotherapy. WU Record 7/10/20, Matthew J. Walter, MD, has been named the inaugural Edward P. Evans Endowed Professor at Washington University School of Medicine. Employee Self Service Location & Hours. WU Record 11/6/17, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. He will succeed John F. DiPersio, MD, PhD, who joined the Washington University faculty in 1994 and became Chief of the Division of Oncology in 2000. WU Record 4/5/18, Stuart Kornfeld was honored on April 5 at a dinner at the Missouri Botanical Garden in recognition of his outstanding scientific contributions. We look for the same qualities in our applicants across all academic divisions at WashU, and we encourage you to apply to the school that offers courses and majors in which you are most interested at the time . Such information may lead to new ways to prevent or treat breast cancer in African-American women. Siddhartha Devarakonda, Ramaswamy Govindan, and their colleagues found that most never-smokers lung tumors had so-called driver mutations, specific mistakes in the DNA that fuel tumor growth and that can be blocked with a variety of drugs. Researchers at Washington University School of Medicine in St. Louis have received a four-year, $8.8 million grant to ramp up research aimed at unraveling how an individual's risks of cardiometabolic diseases, such as heart disease and Type 2 diabetes, are influenced by the interaction of specific genes with demographic and lifestyle factors. . Genome sequencing and protein analysis of the tumors will be performed to seek clues to how some of them develop drug resistance. European Urology 2016 Jul 22 | WU Record 8/2/16, Foluso Ademuyiwa and her colleague Laura Beirut (Department of Psychiatry) are launching a major study in African-American women with breast cancer to learn whether their genetic risks are influenced by the same mutations that affect white women or are altogether different mutations. Allergy and Immunology Bioorganic Chemistry and Molecular Pharmacology Bone and Mineral Diseases 314-454-6050 | Fax: 855-887-7850. The Washington University SPORE, led by Dan Link is one of only three academic centers in the U.S. to receive this grant. The division was previously led by John Atkinson, MD (1976-1992 and 2008-2017), Wayne Yokoyama, MD (1995-2007), and . The Division of Rheumatology comprises twenty-five full-time and part-time faculty and staff members who contribute to the clinical care, research and educational mission at Washington University School of Medicine in St. Louis. St. Louis, MO 63110-1093. The study lays the foundation for finding new ways to treat prostate cancer, particularly for the most aggressive forms of the disease. Washington University School of Medicine. WU Record 6/4/21 | NEJM 2021 Jun 4, Stuart Kornfeld is one of six people who received honorary degrees at Washington University's commencement on May 20-21. Division of Endocrinology, Metabolism & Lipid Research . Contact Research. All publications since October, 2022 Click on a highlighted name to view an author's profile. Click on a title or citation to view the article in PubMed. All divisions offer post-graduate training . 12/Missouri Valley . Danforth University Center, Suite 200. WU Record 5/18/16, Ramaswamy Govindan has been named the Anheuser-Busch Endowed Chair in Medical Oncology. Lee to lead pulmonary & critical care division - Washington University School of Medicine in St. Louis Visit the News Hub News Release Lee to lead pulmonary & critical care division Pulmonologist specializes in body's response to lung infections by Julia Evangelou Strait November 22, 2022 Anna Rosengart Our faculty in each division and their individual sections are world leaders in their subspecialties. For more information select a division below. Li Ding, assistant director of The McDonnell Genome Institute at Washington University, and scientists from about 20 other institutions have completed the genetic analyses of more than 11,000 tumors from patients, spanning 33 types of cancer - all part of The Cancer Genome Atlas (TCGA) project. Washington University has ongoing commitments to the initiatives that will continue to shape our ever changing world: We want to consider the issues around the cultural impact of the science that were doing. Many of our dermatologists are also named Best Doctors in America . The Division of Biostatistics is a medical school-wide facility that engages in research, biostatistical consultation, teaching and training. The results will help researchers design better immunotherapies against cancer. A new study in mice led by Miriam Kim and John DiPersio shows that additional treatment with an immunity-boosting protein called interleukin 7 (IL-7) causes the cancer-fighting CAR-T cells to grow in number and become more effective at killing tumor cells. The Anheuser-Busch Foundation established the endowed chair in 2001. Connecting investigators from multiple disciplines who collaborate on innovative projects that affect public health and clinical care. We are committed to learning and exploration, to discovery and impact. By studying this group of patients, the investigators hope to understand the differences between those patients who go on to develop MDS and those who dont. WU Record 10/15/19, Mark Sands and his colleagues have discovered the precise biochemical pathway leading to Krabbe disease, a fatal genetic disorder in children that results in seizures, developmental regression and death, usually around age 3. 314-454-2527 | Fax: 314-747-8880. Telomere Biology Disorders: Time for Moving Towards the Clinic? Our team in Student Affairs helps create an environment where you can study, make new friends, develop lifelong habits of well-being, and where you will thrive! Remarkably, just over half of all tumors analyzed carry genetic mutations that could be targeted by therapies already approved for use in patients. Submissions are curated by editors and moderators who are experts in the field. . Patients in the Continental United States may refer to Family and Guest Services for assistance with lodging. To provide the highest quality of patient care, surgical education, innovative research and community outreach, the Department of Surgery is organized into 6 divisions. Glatz to lead pediatric cardiology division. Four years ago, Lynn was diagnosed with dementia but decided against having a spinal tap that would have shown whether the cause was Alzheimer's disease. Nature Medicine 2016 Jul 4 | WU Record 7/5/16, Examining databases of proteins 3-Dshapes, a group led by Li Ding has identified more than 850 DNA mutations that appear to be linked to cancer. WU Record 9/16/19 | PNAS 2019 Sep 16, Washington University has received a $5 million grant to establish the Edward P. Evans Myelodysplastic Syndromes Center led by oncologistMatthew Walter. Profiles Laboratories Clinical trials staff Faculty & Staff The division is well-known for its comprehensive program focused on the prevention, early detection and treatment of early- and advanced-stage prostate cancers. About the division: Danforth University Center, Suite 200; studentaffairs@wustl.edu; 314-935-4526; Hours: Mon-Fri 8:30 a.m.-5 p.m. . Division of Gastroenterology Education General Gastroenterology Fellowship Advanced IBD Fellowships Advanced Endoscopy Fellowship Program Past Fellows Patient Care National leaders in digestive and liver diseases For over 50 years, the division has been involved in the treatment, research and training of diseases of the digestive tract. 10 MCC is certified as a Gold level Green Office; 11 MCC is certified as a Silver level Green Office. St. Louis, Mo 63110 (314) 454-6022. Dr. Paul comes to us from the George Washington University . We are Washington University in St. Louis. The division utilizes 27,039 square feet for its research, clinical, and education mission. Newly approved by the Food and Drug Administration (FDA) for types of advanced non-Hodgkin lymphoma in adults, the CAR-T cell therapy harnesses a patients own immune system to fight cancer. It has a total undergraduate enrollment of 8,034 (fall 2021), its setting is city, and the campus size is 169 . 1 Brookings Drive. A phase 1 clinical trial to test the safety of FAK inhibitors in patients with advanced pancreatic cancer is underway. To understand how patients respond to these drugs, the researchers will implant the patients tumors into mice that then will receive the same treatment regimen. Phone. Advancing science through biostatistics and education The Division of Biostatistics is a medical school-wide facility that engages in research, biostatistical consultation, teaching and training. Molecular Microbiology and Microbial Pathogenesis. The official athletics website for the Washington University in St. Louis Directory. Email studentaffairs@wustl.edu. Studying human cancer cells and mice, Brian Van Tine and associates found that a two-drug combination targeting a tumors energy sources could be as effective and less toxic than methotrexate to treat osteosarcoma. We are excited to welcome the members of the fall 2022 entering class! Division surgeons are leaders in offering function-preserving surgical techniques that preserve erection among men with prostate cancer, ejaculation among men with testes cancer, and bladder function among all patients with bladder cancer. Washington University's Department of Orthopedic Surgery is seeking a Division Chief for the Physical Medicine and Rehabilitation (PM&R) Neuro-Rehabilitation Division. In a study led by Li Ding, members of the National Cancer Institutes Clinical Proteomic Tumor Analysis Consortium performed high-resolution and high-depth analyses on 99 glioblastoma tumors. We offer comprehensive gastrointestinal subspecialty care with more than 10,000 gastrointestinal procedures performed annually in our division. Contact Us . For patient appointments, call 314-362-8200. WU Record 5/31/22 | Clin Cancer Res 2022 Apr 14, Cells synthesize 60 to 70 lysosomal hydrolases that must be delivered to the lysosome to allow proper functioning of this organelle. UNIVERSITY COVID-19 INFORMATION A new study suggests a simple blood test may identify which patients are predisposed to developing neurotoxic side effects in the days and weeks after CAR-T cell therapy. Department of Surgery. John T. Milken Department of Medicine Division of Endocrinology, Metabolism and Lipid Research | Washington University School of Medicine in St. Louis Division of Endocrinology, Metabolism & Lipid Research National leaders in the treatment of endocrine and metabolic disorders such as thyroid diseases, diabetes, hyperlipidemia and osteoporosis. The findings may enable development of more effective therapies tailored to patients, based on the genetic characteristics of their cancer cells. Its academic mission centers around biostatistical excellence in clinical, epidemiological and genetic studies. Digestive Diseases Research Cores Center. Benefits eligibility is subject to employment status, full-time equivalent (FTE) workload, and weekly standard hours. Website 660 S. Euclid Ave. St. Louis, MO 63110 (314) 362-8065. WU Record 10/18/17 | Center for Gene & Cellular Immunotherapy, Seeking new treatments for metastatic breast cancer, Kathy Weilbaecher and colleagues have designed nanoparticles that carry chemotherapy and are targeted directly to tumors that have spread to bone. Racial and Socioeconomic Differences in Acral Lentiginous Melanoma Outcomes: A Surveillance, Epidemiology, and End Results Analysis, J Am Acad Dermatol 2022 Oct;87(4):866-867, First-In-Human Phase 1/1b Study to Evaluate Sitravatinib in Patients With Advanced Solid Tumors, TGF-Beta Signaling in Myeloproliferative Neoplasms Contributes to Myelofibrosis Without Disrupting the Hematopoietic Niche, J Clin Invest 2022 Apr 19:e154092; [ahead of print], Structure of the Human GlcNAc-1-Phosphotransferase Subunits Reveals Regulatory Mechanism for Lysosomal Enzyme Glycan Phosphorylation, Nat Struct Mol Biol 2022 Mar 24; [ahead of print], Antibody-Drug Conjugates Plus Janus Kinase Inhibitors Enable MHC-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation, J Clin Invest 2021 Nov 2; [Epub ahead of print], U2af1 Is a Haplo-Essential Gene Required for Hematopoietic Cancer Cell Survival in Mice, J Clin Invest 2021 Sep 21; [Epub ahead of print], Breast Cancer Derived GM-CSF Regulates Arginase 1 in Myeloid Cells to Promote an Immunosuppressive Microenvironment, J Clin Invest 2021 Sep 14; [Epub ahead of print], KTE-X19 for Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukaemia: Phase 2 Results of the Single-Arm, Open-Label, Multicentre ZUMA-3 Study, Sotorasib for Lung Cancers With KRAS P.G12C Mutation, N Engl J Med 2021 Jun 4; [Epub ahead of print], Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers, Proteogenomic and Metabolomic Characterization of Human Glioblastoma, Cancer Cell 2021 Feb 2;S1535-6108(21)00050-7, Metabolic Compensation Activates Pro-Survival mTORC1 Signaling Upon 3-Phosphoglycerate Dehydrogenase Inhibition in Osteosarcoma, TPL2 Enforces RAS-Induced Inflammatory Signaling and Is Activated by Point Mutations, J Clin Invest 2020 Jun 23; [Epub ahead of print], Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer, Potently Cytotoxic Natural Killer Cells Initially Emerge From Erythro-Myeloid Progenitors During Mammalian Development, Exploring the "Minimal" Structure of a Functional ADAMTS13 by Mutagenesis and Small-Angle X-Ray Scattering, Posttranscriptional Modulation of TERC by PAPD5 Inhibition Rescues Hematopoietic Development in Dyskeratosis Congenita, Mutation Clearance After Transplantation for Myelodysplastic Syndrome, N Engl J Med 2018 Sep 13;379(11):1028-1041, An "Off-The-Shelf" Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies. Mail Stop 8121-022-07. The new mouse study shows that IL-7 increases the number of T cells in the tumor and other immune organs, which then attack the cancer cells and improve survival. WU Record 4/30/19, Washington University School of Medicine has received a $9 million grant from the National Institutes of Health to study the life histories of breast and pancreatic cancers. A grant from the National Cancer Institute will support anew research center led by Washington University (Ramaswamy Govindan, PI) and collaborators at the Broad Institute of MIT and Harvard. View contacts WU Record 10/9/20 | Cell 2020 Oct 2, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis has been recognized once again as a top U.S. cancer institution, based on a review of its research programs. WU Record 7/30/19, In collaboration with investigators at Rush University in Chicago, David DeNardo and colleagues have found a chemical compound that promotes a vigorous immune assault against pancreatic cancer in mice. WU Record 5/5/21, The Zika virus that ravaged the Americas, leaving many babies with permanent brain damage, may have a silver lining, according to a study published by Milan Chheda and colleagues. At the successful completion of the fellowship program, residents will have a broad exposure to all aspects of cardiothoracic surgery. John T. Milliken Department of Medicine. Department of Pediatrics. The Washington University Senescence Tissue Mapping Center, led by principal investigator Li Ding will map out senescent cells in bone marrow and liver samples in an effort to understand their spatial distribution and molecular signature in different tissue environments and at different ages. Journal of Experimental Medicine 2017 Sep 5 | WU Record 9/5/17 | Outlook Magazine winter 2017/18, John DiPersio, Chief of the Division of Oncology, has received a $6 million outstanding investigator award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support research aimed at improving therapies for leukemia. Tweets by WashUNeurology Division Resources | Internal Use Only. WU Record 6/29/21 | Clin Cancer Res 2021 Jun 29, The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation in the KRAS gene, according to results of a global phase 2 clinical trial. Brian Gordon Assistant Professor, Radiology We want to apply our findings in ways that wont cause more disparities, wont cause stigmatization., America has long had the highest rates of poverty among the wealthy industrialized countries Rather than providing support to the poor, U.S. social policies appear designed to punish and stigmatize them., Herbert S. Hadley Professor of Social Welfare, Computing challenges today are data-intensive. For North American referrals, physicians may call the Barnes-Jewish Hospital Doctors Access Line at (800) 252-DOCS (3627). John T. Milliken Department of Internal Medicine. Please note that all salary figures are approximations based upon third party submissions to Indeed. CIS Search Learn more Dermatologic & Cosmetic Surgery The dermatologic surgeons at Washington University provide comprehensive surgical procedures, as well as a range of cosmetic services. Transplant Nephrologist Rohan Paul Joins WashU Nephrology Faculty. 660 South Euclid Avenue. Campus Box 8115. Its purpose is to help doctors match cancer mutations found in patients tumors with drugs that target such genetic errors. Cancer Research 2017 Aug 30 | WU Record 9/25/17, Children with dyskeratosis congenita - characterized by short telomeres - experience progressive bone marrow failure, eventually losing the ability to make red blood cells, white blood cells and platelets. St. Louis, MO. The urologists in the Washington University Division of Urology are national leaders in the field of urology. The grant will fund a clinical trial of the HER2 inhibitor neratinib in combination with fulvestrant in patients with metastatic breast tumors that have HER2 mutations and are estrogen-receptor positive. We want you to engage with your peers and with your university, to create an experience where you can learn and grow. Evolution, Ecology and Population Biology. They also are leaders inusing minimally invasive surgical techniques, which greatly reduce the need for large incisions and blood loss during surgery; these procedures include the use of laparoscopy, percutaneous renal (kidney) surgery, cystoscopic and ureteroscopic surgery, and lithotripsy for treating a wide range of tumors and other conditions. Its academic mission centers around biostatistical excellence in clinical, epidemiological and genetic studies. Stem Cell Reports 2017 Aug 8 | WU Record 7/27/17, Studying mice with breast tumors transplanted from patients, a group at Washington University led by Li Ding, in collaboration with colleagues at The Broad Institute of MIT and Harvard and Baylor College of Medicine, have analyzed the proteins present in these tumors. The university's Division of Dermatology has a team of board-certified dermatologists offering advanced skin care and treatment for adults and children. To learn more, please visit Washington University Physicians. Department of Otolaryngology. Explore our Programs Find a Consultant . St. Louis, MO 63110. Department of Pediatrics. WU Record 1/14/22 | Clin Cancer Res 2022 Jan 14, An aggressive chemotherapy regimen is the first-line treatment for pancreatic cancer, but the side effects can be severe, and many tumors stop responding to treatment. See Diversity Efforts Featured Stories You are also asked to select a primary academic interest on your application, but you don't need to formally declare your major until your second year on campus. To learn more, please visit Washington University Physicians. They showed how blocking the downstream effects of these mutations can lead to normal production of blood cells. Department of Medicine Announcement. You will be asked to select an academic division on your application for admission to WashU. INSTITUTE FOR INFORMATICS (I2) COVID-19 INFORMATION, Biostat Staff Page Developmental, Regenerative and Stem Cell Biology. Phone: 314-362-1700 | Fax: 314-362-9878. hospitalist@wustl.edu. Washington University School of Medicine. There are six convenient office locations. Dr.Majerus will be responsible for the clinical operations, clinical research and clinical training aspects and Dr.Oh will be responsible for the basic and translational research aspects of the Division. Responsibilities include leadership, strategy, and day-to-day oversight of the Division, ensuring alignment with the goals and objectives of the . Men's Soccer - Washington University in St. Louis The official Men's Soccer page for the Washington University in St. Louis The official Men's Soccer page for the Washington University in St. Louis The official Men's Soccer page for the Washington University in St. Louis Skip To Main Content Washington University in St. Louis Scoreboard Nature Medicine 2016 | WU Record 1/5/16. WU Medicine News, A recent study led by Kian-Huat Lim suggests that blocking IRAK4, a major inflammatory pathway that is activated in pancreatic cancer, makes the tumors sensitive to chemotherapy and a type of immunotherapy that prompts the immune systems T cells to attack the cancer cells. We are a community where you can be an individual and achieve exceptional things. Both studies appear in the August 31 issue of PLOS Medicine, which is a special issue of the journal dedicated to liquid biopsies. These studies helped to create a foundation for the Cancer Genome Atlas, elucidated many previously unknown drivers of AML, and defined the role of clonal heterogeneity in AML progression and relapse. 2022 Washington University in St. Louis . Division of Infectious Diseases. Division of Academic Pediatrics. Education: 314-454-7376. Facebook Division of Pediatric Critical Care Medicine. Aisha Adedayo of #WashU25 has energy and an entrepreneurial spirit. The Division of Nephrology at Washington University School of Medicine welcomes transplant nephrologist Rohan Singh Paul, MBBS, who joined us as Assistant Professor of Medicine on November 1, 2022. Our division has a strong presence in clinical, translational, and basic research. 314-454-6300. academicpediatrics@wustl.edu Suite 6110 - Campus Box 8235. ASH press release 6/6/22 | Wash U HFFTP website. 660 S. Euclid Ave. Campus Box 8116. . The Washington University Dermatopathology Center is committed to providing expert interpretation of both routine and complex skin, hair and nail biopsy specimens. It ranks among the nation's leading institutions in higher education, with exceptionally broad and deep university-wide strengths in . Nature Genetics 2016 Jun 13 | WU Record 6/13/16, Tim Ley is being recognized for his pioneering research in cancer genomics. WU Record 2/17/16, Li Ding and co-workers developed a software tool for finding a certain type of genetic error that has been consistently missed by cancer genome studies. WU Record 7/29/16, David DeNardo, Andrea Wang-Gillam and their colleagues have shown that immunotherapy against pancreatic cancer can be effective when given in conjunction with focal adhesion kinase (FAK) inhibitors, drugs that break up the fibrous tissue in these tumors. Division of General Medicine. We need to crunch tons of data, which creates a performance bottleneck at the interface of the processor and the memory., Associate Professor of Electrical & Systems Engineering, Featured titles from Washington University's faculty and alumni. The strategy, developed in mouse studies, lets chemotherapy penetrate the protective environment of bone and minimizes toxic side effects. Use this page as a starting guide for exploring St. Louis. We are committed to learning and exploration, to discovery and impact. MSC 8124-0086-09. About St. Louis 2022 Washington University in St. Louis . November 28, 2022. Nature Communications 2017 Mar 28 | WU Record 3/28/17, A group led by Obi and Malachi Griffith has developed an online "knowledgebase" to gather and organize information on cancer genomics, providing an educational forum for dissemination of information and discussion of the clinical significance of cancer genome alterations. WU Record 11/29/18, Extending its standing as one of the top leukemia programs in the United States, Washington University School of Medicine has been awarded an $11.5 million grant to further high-level investigations into leukemia and related blood cancers. Patients may benefit when indels are found in genes that already have drugs designed to counter the effects of mutation. Washington University School of Medicine in St. Louis offers outstanding fellowship training in infectious diseases, combining rigorous clinical and research opportunities for the motivated learner seeking to grow in an innovative environment. Division of Gastroenterology. Down-regulation of PCAT-14 is associated with a greater probability of metastatic progression, and this finding may help to determine the intensity of therapy in individual patients. Learn more about the division Division Leadership & Faculty The Public Health Sciences division is led by Graham Colditz, MD, DrPH, an internationally recognized leader in cancer prevention. Their findings are reported in six papers published April 5 in the journals Cell, Cell Reports and Cell Systems. studentaffairs@wustl.edu. His work on the trafficking of proteins to lysosomes via the mannose-6-phosphate pathway led to new understandings of inherited disorders known as lysosomal storage diseases. by Julia Evangelou Strait October 25, 2021. Explore the source How language impacts political opinions Read the story FAQ, SAS Documentation Division of Maternal-Fetal Medicine & Ultrasound | Obstetrics & Gynecology | Washington University in St. Louis Division of Maternal-Fetal Medicine & Ultrasound Chief: Anthony Odibo, MD, MSCE The Division of Maternal Fetal Medicine and Ultrasound provides comprehensive assessment, care and consultation to pregnant women and their physicians. WU Record 6/28/22, Advances in cellular immunotherapy that spur genetically modified T cells (CAR-T cells) to attack cancer cells have revolutionized the treatment of certain blood cancers. 1/No. Division Chief Rhinology and Skull Base Surgery, Department of Otolaryngology, Washington University in St. Louis St Louis, Missouri, United States 914 followers 500+ connections The worlds first removal of a patients kidney through laparoscopic surgery was performed at Washington University School of Medicine in 1990. Senior Leadership | Division of Student Affairs | Washington University in St. Louis Senior Leadership Anna Gonzalez, PhD Vice Chancellor for Student Affairs 314-935-4526 Dr. Anna Gonzalez (she/her) is a nationally recognized student affairs leader with almost 30 years experience in higher education. Living in St Louis. Molecular Genetics and Genomics. Vice Chancellor for Student Affairs. Alone, the compound reduces pancreatic tumor growth and metastases. Board-certified or board-eligible urologists in all urologic subspecialties offer a wide range of leading-edge treatment options both surgical and nonsurgical for medical conditions of the urogenital tract, including the prostate and testicles in males and the kidneys and bladder in both males and females. Here are a few highlights: 1983: In vitro fertilization (IVF) program - the first in St. Louis - begins in partnership with Jewish Hospital. Their strategy combines the targeted elimination of blood-forming stem cells in the bone marrow with immune-modulating drugs to prevent the immune system from rejecting the new donor stem cells. Washington University in St. Louis is a private institution that was founded in 1853. Cell Reports 2017 Jan 24 | WU Record 1/24/17, A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place. Both Oncology floors in the Mid Campus Center participate in the Green Office Program, which aims to encourage offices across all WashU campuses to be champions of our universitys sustainability ethic. Brian Van Tine and his colleagues have developed a way to attack this tumor using an investigational drug that triggers cell death. Critical for this process is the enzyme GlcNAc-1-phosphotransferase which specifically adds a Man-6-P tag to the lysosomal hydrolases that directs the cells transport machinery to deliver the hydrolases to the lysosome. Overall admission percentages within our divisions may vary from year to year. People | Division of Urologic Surgery | Washington University in St. Louis People Urologists in the Division of Urologic Surgery are part of the Washington University Physicians medical group, which is recognized as an international leader in providing innovative, high-quality medical care. Led by Li Ding and colleagues in the Departments of Surgery and Radiology, the research will focus on how breast cancer evolves in response to treatments and how some tumors develop resistance to these treatments. Studying a mouse model, they also identified a possible therapeutic strategy for this disease. December 1, 2022. Inflammatory Bowel Disease. The work will be carried out by a research team of physicians and scientists at the Alvin J. Siteman Cancer Center and Washington University School of Medicine with broad expertise in multiple myeloma, genomics, immunology and immunotherapy, imaging and pharmacogenomics. These results form the basis of a planned clinical trial in patients with sarcomas. At WashU, we strive to provide a best-in-class student experience. 660 S. Euclid Ave. MSC 8208-16-01. Among the medical conditions treated by this practice and treatment options it offers are the following: Kidney stone diseaseProstate cancerBenign prostate diseaseBladder cancerTesticular cancerKidney cancerFemale urinary incontinenceMale sexual dysfunctionMale infertilityPediatric urologic surgeryReconstructive surgery. Divisions To better serve our mission of excellence in patient care, research and education, the department is divided into specialty divisions that focus on specific areas of internal medicine. Division of Bone and Mineral Diseases | Washington University in St. Louis JOHN T. MILLIKEN DEPARTMENT OF INTERNAL MEDICINE Division of Bone and Mineral Diseases About Us Patient Care Education Research News Events More Contact Giving The home for bone health Here you'll find an array of resources and opportunities that support our meaningful commitment to diversity, equity and inclusion. Washington University Urology is committed to helping you manage your health and is now offering virtual patient visits. The information may expand the number of cancer patients who can benefit from existing drugs. Diversity & Inclusion Ideals & Action We're making strides on campus and in health-care professions to build a culture that is diverse, inclusive and equitable. Campus Box 8226, St. Louis, MO 63110-1093 (800) 852-9074. dbbs-info@wustl.edu. Dr. Link is the Alan A. and Edith L. Wolff Distinguished Professor of Medicine and Professor of Pathology and Immunology at Washington University School of Medicine. The knowledge could help guide treatment decisions. Warmly, Anna "Dr. G" Gonzalez. Washington University. Courtesy photo. WU Record 8/21/19, More than 50 years ago, Stuart Kornfeld, was awarded his first research grant. Life at WashU > Our Students Class of 2026 Profile Our selection process is guided by a diverse committee of admissions professionals in an effort to ensure that, together, our five academic divisions create a community that is welcoming, nurturing, and intellectually rigorous. Washington University in St. Louis Men's Soccer Program Information Powered by One Brookings Drive Saint Louis, MO 63130 (314) 935-5000 http://www.wustl.edu Year Founded: 1853 Religious Affiliation: None College Type: Private , Suburban Enrollment: 7653 (full time undergrad) Tuition In State: $57,750 Tuition Out of State: $57,750 Division: WU Record 1/26/21 | Cell Reports 2021 Jan 26, Research published by Ramon Jin, a clinical fellow in the Division of Medical Oncology, and co-workers in Jason Mills's laboratory suggests that people with Barretts esophagus (a major risk factor for cancer of the esophagus) may be vulnerable to infection after swallowing the virus that causes COVID-19. All first-year students come into WashU . His research has laid the groundwork for precision medicine in cancer treatment, which uses the genetic makeup of a patients tumor and how it responds to therapy as a guide for how best to attack that specific patients disease. Contact Us Two studies co-authored by Vivek Arora and Angela Hirbe describe the potential of liquid biopsies to identify and track tumor growth in two very different cancers: bladder cancer and peripheral nerve sheath tumors. His studies have laid the groundwork for precision medicine in cancer, which targets treatment to a patient based on the genetic makeup of a tumor and how it responds to therapy. Computational and Systems Biology. Janet S. Lee, MD, a highly regarded physician-scientist in pulmonary and critical care medicine, has been chosen to lead the Division of Pulmonary & Critical Care Medicine in the Department of Medicine at Washington University School of Medicine in St. Louis. Daniel C. Link, MD,has been named the new Chief of the Division of Oncology in the Department of Medicine and Deputy Director of the Siteman Cancer Center effective December 1, 2022. Seminars WashU is a world-class research university with our roots firmly in St. Louis. But when combined with immunotherapy, the compound significantly shrank tumors and dramatically improved survival in the animals. Washington University School of Medicine Facts . WU Record 3/24/21 | JCI Insight 2021 Jan 11, A new study led by David Spencer suggests whole genome sequencing is a reliable and practical approach for detecting all of the changes that are important for assessing the risk of relapse for AML and MDS patients. He is best known for the study of how sugars attach to proteins and the roles these molecules play in how cells function. Mailing Address. Studying mice, they found that the drug also may reduce some of the damaging side effects of the chemotherapy cocktail FOLFIRINOX (a combination of folinic acid, 5-fluorouracil, irinotecan and oxaliplatin), commonly used to treat pancreatic cancer. St. Louis, MO 63110. oto@wustl.edu. Analyzing blood samples from patients before, during and after CAR-T cell therapy, Omar Butt and colleagues found that levels of a protein called neurofilament light chain (NfL) are higher in patients who go on to develop neurotoxic complications. WU Record 11/10/21 | J Clin Invest 2021 Nov 2, Washington University is joining a new NIH research network focused on the study of senescent cells, a rare population of cells that are vital for understanding diseases of aging, including cancer and neurodegeneration. St. Louis, MO 63110-1093. Division of Palliative Medicine. WU Record 11/6/18, A study led by Matthew Christopher, Allegra Petti, Michael Rettig and Timothy Ley offers a potential explanation for why many AML patients experience a relapse after a stem cell transplant and suggests a therapeutic approach that may help to place relapsed patients back into remission. Washington University in St. Louis is committed to providing a comprehensive and competitive benefits package to our employees. Many of our skin doctors participate in clinical research giving patients access to new drug therapies and treatments. 660 S. Euclid Ave. St. Louis, MO 63110. LEARN ABOUT THE DIVISION. WU Record 10/18/21 | J Clin Oncol 2021 Oct 18, About 78-92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patients tumor. Leukemia 2018 Apr 2 | WU Record 4/24/18, Researchers nationwide have reached a major milestone in describing the genetic landscape of cancer. Immunology. They used computer modeling to accurately predict 75% of effective neoantigens and eliminate 98% of ineffective mutant proteins in melanoma and a common type of lung cancer. Misdirected or malformed lysosomal proteins can lead to lysosomal storage diseases, such as Tay-Sachs disease and Niemann-Pick disease. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Dong J, Adhikary S, Zhou L, Schuberth PC, Faghmous I, Masouleh BK, Houot R J Hematol Oncol 2022 Dec 10;15(1):170, Montoya LM, Kosorok MR, Geng EH, Schwab J, Odeny TA, Petersen ML Biometrics 2022 Dec 9; [ahead of print], Meroni A, Grosser J, Agashe S, Ramakrishnan N, Jackson J, Verma P, Baranello L, Vindigni A Sci Adv 2022 Dec 9;8(49):eabq0648, Covut F, Sanfilippo KM Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):363-367, Tian R, Wiley B, Liu J, Zong X, Truong B, Zhao S, Uddin MM, Niroula A, Miller CA, Mukherjee S, Heiden BT, Luo J, Puri V, Kozower BD, Walter MJ, Ding L, Link DC, Amos CI, Ebert BL, Govindan R, Natarajan P, Bolton KL, Cao Y J Clin Oncol 2022 Dec 8:JCO2200857; [ahead of print], Kim S, Lim S, Kim B, Ritchey J, Vij K, Prior J, Marsala L, Stoner A, Gao F, Achilefu S, Cooper ML, DiPersio JF, Choi J Blood 2022 Dec 7:blood2021012687; [ahead of print], Barlin M, Erdmann-Gilmore P, Mudd JL, Zhang Q, Seymour RW, Guo Z, Miessner JR, Goedegebuure SP, Bi Y, Osorio OA, Alexander-Brett J, Li S, Ma CX, Fields RC, Townsend RR, Held JM Mol Cell Proteomics 2022 Dec 2:100476; [ahead of print], Tepper SC, Holten AK, Jeffe DB, England PH, Hong ZL, Perez M, Ghert M, Hirbe AC, Cipriano CA Surg Oncol 2022 Dec;45:101861, Al-Kadhimi Z, Callahan M, Fehniger T, Cole KE, Vose J, Hinrichs S Int Immunopharmacol 2022 Dec;113(Pt A):109387, Kitko CL, Arora M, DeFilipp Z, Zaid MA, Di Stasi A, Radojcic V, Betts CB, Coussens LM, Meyers ML, Qamoos H, Ordentlich P, Kumar V, Quaranto C, Schmitt A, Gu Y, Blazar BR, Wang TP, Salhotra A, Pusic I, Jagasia M, Lee SJ J Clin Oncol 2022 Dec 2:JCO2200958; [ahead of print], Berchuck JE, Facchinetti F, DiToro DF, Baiev I, Majeed U, Reyes S, Chen C, Zhang K, Sharman R, Uson Junior PLS, Maurer J, Shroff RT, Pritchard CC, Wu MJ, Catenacci DVT, Javle M, Friboulet L, Hollebecque A, Bardeesy N, Zhu AX, Lennerz JK, Tan B, Borad M, Parikh AR, Kiedrowski LA, Kelley RK, Mody K, Juric D, Goyal L Ann Oncol 2022 Dec;33(12):1269-1283, SanMiguel JM, Eudy E, Loberg MA, Young KA, Mistry JJ, Mujica KD, Schwartz LS, Stearns TM, Challen GA, Trowbridge JJ Cancer Discov 2022 Dec 2;12(12):2763-2773, Lander VE, Belle JI, Kingston NL, Herndon JM, Hogg GD, Liu X, Kang LI, Knolhoff BL, Bogner SJ, Baer JM, Zuo C, Borcherding NC, Lander DP, Mpoy C, Scott J, Zahner M, Rogers BE, Schwarz JK, Kim H, DeNardo DG Cancer Discov 2022 Dec 2;12(12):2774-2799, Slade M, Martin TG, Nathwani N, Fiala MA, Rettig MP, Gao F, Deol A, Buadi FK, Kaufman JL, Hofmeister CC, Gregory TK, Berdeja J, Chari A, Rosko A, Vij R Leukemia 2022 Dec;36(12):2917-2921, Goldsmith SR, Streeter S, Covut F Curr Hematol Malig Rep 2022 Dec;17(6):286-297, De Togni E, Wan F, Slade M, Plach K, Abboud R Leuk Lymphoma 2022 Dec;63(12):2975-2981, Lavasidis G, Markozannes G, Voorhies K, Trikalinos NA, Petridou ET, Panagiotou OA, Ntzani EE Crit Rev Oncol Hematol 2022 Dec;180:103845, McHenry S, Zong X, Shi M, Fritz CDL, Pedersen KS, Peterson LR, Lee JK, Fields RC, Davidson NO, Cao Y Hepatol Commun 2022 Dec;6(12):3299-3310, Dehdashti F, Reimers MA, Shoghi KI, Chen DL, Luo J, Rogers B, Pachynski RK, Sreekumar S, Weimholt C, Zhou D Mol Imaging Biol 2022 Dec;24(6):853-861, Patel DA, Kahl BS Cancer 2022 Dec 1;128(23):4047-4051, Wang TF, Sanfilippo KM, Douketis J, Falanga A, Karageorgiou J, Maraveyas A, Ortel TL, Soff G, Vedantham S, Zwicker JI J Thromb Haemost 2022 Dec;20(12):3026-3038, Ji JX, Cochrane DR, Negri GL, Colborne S, Spencer Miko SE, Hoang LN, Farnell D, Tessier-Cloutier B, Huvila J, Thompson E, Leung S, Chiu D, Chow C, Ta M, Kobel M, Feil L, Anglesio M, Goode EL, Bolton K, Morin GB, Huntsman DG J Pathol 2022 Dec;258(4):325-338, Trikalinos NA, Hammill C, Liu J, Navale P, Winter K, Chatterjee D, Iravani A, Amin M, Itani M Abdom Radiol (NY) 2022 Dec;47(12):4096-4102, Yano M, Shetty AS, Williams GA, Lancia S, Trikalinos NA, Hammill CW, Hawkins WG, Salter A, Chatterjee D Abdom Radiol (NY) 2022 Dec;47(12):3971-3985, Khaddour K, Zhou A, Butt OH, Budde G, Malashevich AK, Ansstas G Front Oncol 2022 Nov 17;12:978996, Heiden BT, Eaton DB, Chang SH, Yan Y, Schoen MW, Thomas TS, Patel MR, Kreisel D, Nava RG, Meyers BF, Kozower BD, Puri V J Natl Cancer Inst 2022 Nov 29:djac208; [ahead of print], Grierson PM, Tan B, Pedersen KS, Park H, Suresh R, Amin MA, Trikalinos NA, Knoerzer D, Kreider B, Reddy A, Liu J, Der CJ, Wang-Gillam A, Lim KH Oncologist 2022 Nov 25:oyac237; [ahead of print], Duncavage EJ, Bagg A, Hasserjian RP, DiNardo CD, Godley LA, Iacobucci I, Jaiswal S, Malcovati L, Vannucchi AM, Patel KP, Arber DA, Arcila ME, Bejar R, Berliner N, Borowitz MJ, Branford S, Brown AL, Cargo CA, Dohner H, Falini B, Garcia-Manero G, Haferlach T, Hellstrom-Lindberg E, Kim AS, Klco JM, Komrokji R, Lee-Cheun Loh M, Loghavi S, Mullighan CG, Ogawa S, Orazi A, Papaemmanuil E, Reiter A, Ross DM, Savona M, Shimamura A, Skoda RC, Sole F, Stone RM, Tefferi A, Walter MJ, Wu D, Ebert BL, Cazzola M Blood 2022 Nov 24;140(21):2228-2247, Berrien-Elliott MM, Jacobs MT, Fehniger TA Blood 2022 Nov 23:blood2022016200; [ahead of print], Ince S, Itani M, Henke LE, Smith RK, Wise PE, Mutch MG, Glasgow SC, Silviera ML, Pedersen KS, Hunt SR, Kim H, Fraum TJ Tomography 2022 Nov 9;8(6):2723-2734, Clifton K, Gao F, Jabbari J, Van Aman M, Dulle P, Hanson J, Wildes TM J Geriatr Oncol 2022 Nov;13(8):1122-1131, Noel MS, Kim S, Hartley ML, Wong S, Picozzi VJ, Staszewski H, Kim DW, Van Tornout JM, Philip PA, Chung V, Ocean AJ, Wang-Gillam A Cancer Med 2022 Nov;11(22):4169-4181, Bowman-Kirigin JA, Desai R, Saunders BT, Wang AZ, Schaettler MO, Liu CJ, Livingstone AJ, Kobayashi DK, Durai V, Kretzer NM, Zipfel GJ, Leuthardt EC, Osbun JW, Chicoine MR, Kim AH, Murphy KM, Johanns TM, Zinselmeyer BH, Dunn GP Cancer Immunol Res 2022 Nov 21:CIR-22-0098; [ahead of print], Berrian J, Liu Y, Ezenwajiaku N, Moreno-Aspitia A, Holton SJ, Toriola AT, Colditz GA, Housten AJ, Hall L, Fiala MA, Ademuyiwa FO Cancer Med 2022 Nov 20; [ahead of print], Bardia A, Mayer I, Winer E, Linden HM, Ma CX, Parker BA, Bellet M, Arteaga CL, Cheeti S, Gates M, Chang CW, Fredrickson J, Spoerke JM, Moore HM, Giltnane J, Friedman LS, Chow Maneval E, Chan I, Jhaveri K Breast Cancer Res Treat 2022 Nov 19; [ahead of print], Rosenbaum E, Chugh R, Ryan CW, Agulnik M, Milhem MM, George S, Jones RL, Chmielowski B, Van Tine BA, Tawbi H, Elias AD, Read WL, Budd GT, Qin LX, Rodler ET, Hirman J, Weiden P, Bennett CM, Livingston PO, Ragupathi G, Hansen D, D'Angelo SP, Tap WD, Schwartz GK, Maki RG, Carvajal RD Eur J Cancer 2022 Nov;176:155-163, Butt OH, Zhou AY, Caimi PF, Luckett PH, Wisch JK, Derenoncourt P, Lee K, Wu GF, de Lima MJG, Campian JL, Frank MJ, DiPersio JF, Ghobadi A, Ances BM JAMA Oncol 2022 Nov 1;8(11):1652-1657, Ghobadi A, Slade M, Kantarjian H, Alvarenga J, Aldoss I, Mohammed KA, Jabbour E, Faramand R, Shah B, Locke F, Fingrut W, Park JH, Short NJ, Gao F, Uy GL, Westervelt P, DiPersio JF, Champlin RE, Al Malki MM, Ravandi F, Kebriaei P Blood 2022 Nov 17;140(20):2101-2112, Pemmaraju N, Kantarjian HM, Sweet KL, Wang ES, Senapati J, Wilson NR, Konopleva MY, Frankel AE, Gupta V, Mesa RA, Ulrickson ML, Gorak E, Bhatia S, Budak-Alpdogan T, Mason JR, Garcia-Romero MT, Lopez-Santiago NC, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I, Duvic M, Rampal RK, de Lima M, Foran JM, Fathi AT, Hall A, Jacoby MA, Lancet JE, Mannis GN, Stein AS, Mims AS, Rizzieri D, Olin RL, Perl AE, Schiller GJ, Shami PJ, Stone RM, Strickland S, Wieduwilt MJ, Daver NG, Ravandi F, Vasu S, Guzman ML, Roboz GJ, Khoury JD, Qazilbash MH, Aung P, Cuglievan B, Madanat YF, Kharfan-Dabaja MA, Pawlowska AB, Taylor J, Tallman MS, Dhakal P, Lane AA Blood 2022 Nov 18:blood2022017865; [ahead of print], Kuruvilla J, Armand P, Hamadani M, Kline J, Moskowitz CH, Avigan D, Brody JD, Ribrag V, Herrera AF, Morschhauser F, Kanate A, Zinzani PL, Bitran J, Ghesquieres H, Schuster SJ, Farooqui M, Marinello P, Bartlett NL Leuk Lymphoma 2022 Nov 18:1-10; [ahead of print], Donahue K, Xie H, Li M, Gao A, Ma M, Wang Y, Tipton R, Semanik N, Primeau T, Li S, Li L, Tang W, Xu W J Biol Chem 2022 Nov 14:102700; [ahead of print], Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML JAMA Oncol 2022 Nov 17; [ahead of print], Salvador C, Mark P, Hoenemeyer T, McDonald V Complement Ther Clin Pract 2022 Nov;49:101639, Chen H, Gesumaria L, Park YK, Oliver TG, Singer DS, Ge K, Schrump DS Mol Cancer Res 2022 Nov 15:MCR-22-0594; [ahead of print], Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S, Reimers M, Kim EH, Thakur MK, Saeed MA, Pachynski RK, Seeliger MA, Todd Miller W, Feng FY, Mahajan NP Nat Commun 2022 Nov 14;13(1):6929, Krysiak K, Danos AM, Saliba J, McMichael JF, Coffman AC, Kiwala S, Barnell EK, Sheta L, Grisdale CJ, Kujan L, Pema S, Lever J, Ridd S, Spies NC, Andric V, Chiorean A, Rieke DT, Clark KA, Reisle C, Venigalla AC, Evans M, Jani P, Takahashi H, Suda A, Horak P, Ritter DI, Zhou X, Ainscough BJ, Delong S, Kesserwan C, Lamping M, Shen H, Marr AR, Hoang MH, Singhal K, Khanfar M, Li BV, Lin WH, Terraf P, Corson LB, Salama Y, Campbell KM, Farncombe KM, Ji J, Zhao X, Xu X, Kanagal-Shamanna R, King I, Cotto KC, Skidmore ZL, Walker JR, Zhang J, Milosavljevic A, Patel RY, Giles RH, Kim RH, Schriml LM, Mardis ER, Jones SJM, Raca G, Rao S, Madhavan S, Wagner AH, Griffith M, Griffith OL Nucleic Acids Res 2022 Nov 14:gkac979; [ahead of print], Bolton KL, Chen D, Corona de la Fuente R, Fu Z, Murali R, Kobel M, Tazi Y, Cunningham JM, Chan ICC, Wiley BJ, Moukarzel LA, Winham SJ, Armasu SM, Lester J, Elishaev E, Laslavic A, Kennedy CJ, Piskorz A, Sekowska M, Brand AH, Chiew YE, Pharoah P, Elias KM, Drapkin R, Churchman M, Gourley C, DeFazio A, Karlan B, Brenton JD, Weigelt B, Anglesio MS, Huntsman D, Gayther S, Konner J, Modugno F, Lawrenson K, Goode EL, Papaemmanuil E Clin Cancer Res 2022 Nov 14;28(22):4947-4956, Zimmerman SM, Nixon SJ, Chen PY, Raj L, Smith SR, Paolini RL, Lin PN, Souroullas GP Oncogene 2022 Nov;41(46):4983-4993, Lee S, Ma C, Shi Q, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Lewis D, Tan B, Goldberg RM, Venook A, Blanke C, O'Reilly EM, Shields AF, Meyerhardt JA J Clin Oncol 2022 Nov 11:JCO2201637; [ahead of print], Akkad N, Kodgule R, Duncavage EJ, Mehta-Shah N, Spencer DH, Watkins M, Shirai C, Myckatyn T Aesthet Surg J 2022 Nov 10:sjac282; [ahead of print], Davis AA, Gerratana L, Clifton K, Medford AJ, Velimirovic M, Hensing WL, Bucheit L, Shah AN, D'Amico P, Reduzzi C, Zhang Q, Dai CS, Denault EN, Bagegni NA, Opyrchal M, Ademuyiwa FO, Bose R, Gradishar WJ, Behdad A, Ma CX, Bardia A, Cristofanilli M EBioMedicine 2022 Nov 1;86:104316; [ahead of print], Goldsmith SR, Ghobadi A, DiPersio JF, Hill B, Shadman M, Jain T Transplant Cell Ther 2022 Nov;28(11):727-736, Cybulla E, Vindigni A Nat Rev Cancer 2022 Nov 2; [ahead of print], Cortese MJ, Wei W, Cerdena S, Watkins MP, Olson M, Jodon G, Kaiser J, Haverkos B, Hughes ME, Namoglu E, Grover NS, Snow A, Orellana-Noia V, Rainey M, Sohail M, Rudoni J, Portell C, Voorhees T, Landsburg DJ, Kamdar M, Kahl BS, Hill BT Leuk Lymphoma 2022 Nov 2:1-12; [ahead of print], Zhu C, Iwase M, Li Z, Wang F, Quinet A, Vindigni A, Shao J Nat Commun 2022 Nov 1;13(1):6531, Sjostrom M, Zhao SG, Levy S, Zhang M, Ning Y, Shrestha R, Lundberg A, Herberts C, Foye A, Aggarwal R, Hua JT, Li H, Bergamaschi A, Maurice-Dror C, Maheshwari A, Chen S, Ng SWS, Ye W, Petricca J, Fraser M, Chesner L, Perry MD, Moreno-Rodriguez T, Chen WS, Alumkal JJ, Chou J, Morgans AK, Beer TM, Thomas GV, Gleave M, Lloyd P, Phillips T, McCarthy E, Haffner MC, Zoubeidi A, Annala M, Reiter RE, Rettig MB, Witte ON, Fong L, Bose R, Huang FW, Luo J, Bjartell A, Lang JM, Mahajan NP, Lara PN, Evans CP, Tran PT, Posadas EM, He C, Cui XL, Huang J, Zwart W, Gilbert LA, Maher CA, Boutros PC, Chi KN, Ashworth A, Small EJ, He HH, Wyatt AW, Quigley DA, Feng FY Cancer Res 2022 Nov 2;82(21):3888-3902, Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, Vashist TD, Huynh AMT, Dou Y, Gou X, Huang C, Shi Z, Wen B, Korchina V, Gibbs RA, Muzny DM, Doddapaneni H, Dobrolecki LE, Rodriguez H, Robles AI, Hiltke T, Lewis MT, Nangia JR, Nemati Shafaee M, Li S, Hagemann IS, Hoog J, Lim B, Osborne CK, Mani DR, Gillette MA, Zhang B, Echeverria GV, Miles G, Rimawi MF, Carr SA, Ademuyiwa FO, Satpathy S, Ellis MJ Cancer Discov 2022 Nov 2;12(11):2586-2605, Stephens DM, Li H, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, Song JY, LeBlanc ML, Smith SM, Persky DO, Friedberg JW Haematologica 2022 Nov 1;107(11):2732-2736, Lim M, Weller M, Idbaih A, Steinbach J, Finocchiaro G, Raval RR, Ansstas G, Baehring J, Taylor JW, Honnorat J, Petrecca K, De Vos F, Wick A, Sumrall A, Sahebjam S, Mellinghoff IK, Kinoshita M, Roberts M, Slepetis R, Warad D, Leung D, Lee M, Reardon DA, Omuro A Neuro Oncol 2022 Nov 2;24(11):1935-1949, D'Souza A, Shah N, Rodriguez C, Voorhees PM, Weisel K, Bueno OF, Pothacamury RK, Freise KJ, Yue S, Ross JA, Polepally AR, Talati C, Lee S, Jin Z, Buelow B, Vij R, Kumar S J Clin Oncol 2022 Nov 1;40(31):3576-3586, Foley NC, Mehta-Shah N Curr Oncol Rep 2022 Nov;24(11):1489-1499, Herzog BH, Waqar SN, Devarakonda S, Ward JP, Gao F, Govindan R, Morgensztern D Lung Cancer 2022 Nov;173:101-106, Kantarjian HM, Jabbour E, Deininger M, Abruzzese E, Apperley J, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton J, Nicolini FE, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Shah NP, Talpaz M, Srivastava S, Ren X, Mauro M Am J Hematol 2022 Nov;97(11):1419-1426, Hou YC, Neidich JA, Duncavage EJ, Spencer DH, Schroeder MC Hum Mutat 2022 Nov;43(11):1519-1530, Pemmaraju N, Harrison C, Gupta V, Verstovsek S, Scott B, Oh ST, Palandri F, Al-Ali HK, Sobas M, McMullin MF, Mesa R, Buckley S, Roman-Torres K, Vannucchi A, Yacoub A EJHaem 2022 Oct 20;3(4):1346-1351, Liu L, Dehner C, Grandhi N, Lyu Y, Borcherding DC, Chrisinger JSA, Zhang X, Luo J, Tao Y, Parkes A, Bui NQ, Davis EJ, Milhem MM, Monga V, Weiss M, Van Tine B, Hirbe AC Genes (Basel) 2022 Oct 24;13(11):1932, Sponagel J, Devarakonda S, Rubin JB, Luo J, Ippolito JE iScience 2022 Oct 12;25(11):105339, Camidge DR, Barlesi F, Goldman JW, Morgensztern D, Heist R, Vokes E, Spira A, Angevin E, Su WC, Hong DS, Strickler JH, Motwani M, Dunbar M, Parikh A, Noon E, Blot V, Wu J, Kelly K J Clin Oncol 2022 Oct 26:JCO2200739; [ahead of print], Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, De La Fuente M, Anderson MD, Shonka N, Damek D, Carrillo J, Kunschner-Ronan LJ, Chaudhary R, Jaeckle KA, Senecal FM, Kaley T, Morrison T, Thomas AA, Welch MR, Iwamoto F, Cachia D, Cohen AL, Vora S, Knopp M, Dunn IF, Kumthekar P, Sarkaria J, Geyer S, Carrero XW, Martinez-Lage M, Cahill DP, Brown PD, Giannini C, Santagata S, Barker FG 2nd, Galanis E J Clin Oncol 2022 Oct 26:JCO2102371; [ahead of print], Tesfazghi MT, Bass AR, Al-Hammadi N, Woller SC, Stevens SM, Eby CS, Scott MG, Snyder L, Wildes TS, Gage BF Cardiol Res Pract 2022 Oct 14;2022:8244047, Shim KG, Crain M, Augustin K, Oetjen KA Leuk Res Rep 2022 Oct 19;18:100353, Barnell EK, Fisk B, Skidmore ZL, Cotto KC, Basu A, Anand A, Richters MM, Luo J, Fronick C, Anurag M, Fulton R, Ellis MJ, Griffith OL, Griffith M, Ademuyiwa FO Sci Rep 2022 Oct 22;12(1):17732, Shree Bose (Authors include: Chheda MG) Cancer Cell 2022 Oct 18:S1535-6108(22)00475-5; [ahead of print], LaCasce AS, Dockter T, Ruppert AS, Kostakoglu L, Schoder H, Hsi E, Bogart J, Cheson B, Wagner-Johnston N, Abramson J, Blum K, Leonard JP, Bartlett NL J Clin Oncol 2022 Oct 21:JCO2200947; [ahead of print], Epperla N, Zhao Q, Mullick Chowdhury S, Shea L, Moyo T, Reddy N, Sheets JW, Weiner DM, Ramakrishnan Geethakumari P, Kandarpa M, Jordan Bruno X, Thomas C, Churnetski MC, Hsu A, Zurbriggen LD, Tan XC, Lindsey KG, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Oh TS, Karmali R, Kim SH, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova ER, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G Blood Adv 2022 Oct 21:bloodadvances2022008634; [ahead of print], Li QK, Hu Y, Chen L, Schnaubelt M, Cui Zhou D, Li Y, Lu RJ, Thiagarajan M, Hostetter G, Newton CJ, Jewell SD, Omenn G, Robles AI, Mesri M, Bathe OF, Zhang B, Ding L, Hruban RH, Chan DW, Zhang H Clin Proteomics 2022 Oct 20;19(1):36, Ghobadi A, Landmann JH, Carter A, Cooper ML, Selli ME, Chang J, Baker M, Miller CA, Ferraro F, Chen DY, Smith AM, LaValle TA, Duncavage EJ, Chou J, Tam V, Benoun JM, Nater J, Scholler N, Milletti F, Vezan R, Bot A, Rossi JM, Singh N Blood Adv 2022 Oct 25;6(20):5634-5640, Nelvagal HR, Eaton SL, Wang SH, Eultgen EM, Takahashi K, Le SQ, Nesbitt R, Dearborn JT, Siano N, Puhl AC, Dickson PI, Thompson G, Murdoch F, Brennan PM, Gray M, Greenhalgh SN, Tennant P, Gregson R, Clutton E, Nixon J, Proudfoot C, Guido S, Lillico SG, Whitelaw CBA, Lu JY, Hofmann SL, Ekins S, Sands MS, Wishart TM, Cooper JD J Clin Invest 2022 Oct 17;132(20):e163107, Barnell EK, Skidmore ZL, Newcomer KF, Chavez M, Campbell KM, Cotto KC, Spies NC, Ruzinova MB, Wang T, Abro B, Kreisel F, Parikh BA, Duncavage EJ, Frater JL, Lee YS, Hassan A, King J, Kohnen DR, Fiala MA, Welch JSS, Uy GL, Vij K, Vij R, Griffith M, Griffith OL, Wartman LD Blood Adv 2022 Oct 17:bloodadvances2022007496; [ahead of print], Li S, Bern MD, Miao B, Fan C, Xing X, Inoue T, Piersma SJ, Wang T, Colonna M, Kurosaki T, Yokoyama WM Elife 2022 Oct 3;11:e77294, LCMC study investigators (Authors include: Waqar SN) Nat Med 2022 Oct;28(10):2155-2161, Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Jeck W, Johung KL, Kirilcuk N, Krishnamurthi S, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stotsky-Himelfarb E, Tavakkoli A, Willett CG, Gregory K, Gurski L J Natl Compr Canc Netw 2022 Oct;20(10):1139-1167, Sanft T, Day A, Peterson L, Rodriguez MA, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Broderick G, Demark-Wahnefried W, Dickinson K, Fairman NP, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett ED, Patel C, Pirl W, Porpiglia A, Ruddy KJ, Schapira L, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Yang EH, Zee P, McMillian NR, Freedman-Cass DA J Natl Compr Canc Netw 2022 Oct;20(10):1080-1090, International Replication Repair Deficiency Consortium (Authors include: Peterson L) J Clin Oncol 2022 Oct 14:JCO2102873; [ahead of print], Wang-Gillam A, Lim KH, McWilliams R, Suresh R, Lockhart AC, Brown A, Breden M, Belle JI, Herndon J, Bogner SJ, Pedersen K, Tan B, Boice N, Acharya A, Abdiannia M, Gao F, Yoon HH, Zhu M, Trikalinos NA, Ratner L, Aranha O, Hawkins WG, Herzog BH, DeNardo DG Clin Cancer Res 2022 Oct 13:CCR-22-0308; [ahead of print], Kossenkov AV, Milcarek A, Notta F, Jang GH, Wilson JM, Gallinger S, Zhou DC, Ding L, Ghosh JC, Perego M, Morotti A, Locatelli M, Robert ME, Vaira V, Altieri DC PLoS One 2022 Oct 12;17(10):e0273520, Brotherton T, Burton S, Knoche E, Presti M ACG Case Rep J 2022 Oct 6;9(10):e00869, Yi J, Miller AT, Archambault AS, Jones AJ, Bradstreet TR, Bandla S, Hsu YS, Edelson BT, Zhou YW, Fremont DH, Egawa T, Singh N, Wu GF, Hsieh CS Sci Immunol 2022 Oct 14;7(76):eabo0777, Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringden O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO Transplant Cell Ther 2022 Oct;28(10):681-693, Li S, Yao JC, Oetjen KA, Krambs JR, Xia J, Zhang J, Schmidt AP, Helton NM, Fulton RS, Heath SE, Turnbull IR, Mbalaviele G, Ley TJ, Walter MJ, Link DC Blood 2022 Oct 6;140(14):1607-1620, Thomas N, Dreval K, Gerhard DS, Hilton LK, Abramson JS, Barta SK, Bartlett NL, Bethony J, Bhatia K, Bowen J, Bryan AC, Cesarman E, Casper C, Cruz M, Dyer M, Farinha P, Gastier-Foster J, Gerrie AS, Grande B, Greiner TC, Griner N, Gross TG, Harris NL, Irvin JD, Jaffe ES, Henry D, Huppi RL, Leal FE, Lee M, Martin JP, Martin MR, Mbulaiteye SM, Mitsuyasu R, Morris V, Mullighan CG, Mungall AJ, Mungall K, Mutyaba I, Nokta M, Namirembe C, Noy A, Ogwang MD, Omoding A, Orem J, Ott G, Petrello H, Pittaluga S, Phelan JD, Ramos JC, Ratner L, Reynolds SJ, Rubinstein PG, Sissolak G, Slack GW, Soudi S, Swerdlow SH, Traverse-Glehen A, Wilson W, Wong JCH, Yarchoan R, ZenKlusen JC, Marra MA, Staudt LM, Scott DW, Morin RD Blood 2022 Oct 6:blood2022016534; [ahead of print], Heller G, Bradbury AM, Sands MS, Bongarzone ER Mol Ther 2022 Oct 3:S1525-0016(22)00606-2; [ahead of print], Wiley B, Parsons TM, Burkart S, Young AL, Erlandson KM, Tassiopoulos KK, Wu K, Gurnett C, Presti RM, Bolton KL, Challen GA Exp Hematol 2022 Oct;114:18-21, Nickless A, Zhang J, Othoum G, Webster J, Inkman MJ, Coonrod E, Fontes S, Rozycki EB, Maher CA, White NM Mol Cancer Res 2022 Oct 4;20(10):1481-1488, Jagadeesh D, Horwitz S, Bartlett NL, Kim Y, Jacobsen E, Duvic M, Little M, Trepicchio W, Fenton K, Onsum M, Lisano J, Advani R Oncologist 2022 Oct 1;27(10):864-873, Morschhauser F, Nastoupil L, Feugier P, Schiano de Colella JM, Tilly H, Palomba ML, Bachy E, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Le Gouill S, Daguindau N, Guidez S, Pica GM, Garcia-Sancho AM, Lopez-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, Andre M, Kalung W, Sehn LH, Izutsu K, Cartron G, Gkasiamis A, Crowe R, Xerri L, Fowler NH, Salles G J Clin Oncol 2022 Oct 1;40(28):3239-3245, Agarwal N, Tangen CM, Hussain MHA, Gupta S, Plets M, Lara PN, Harzstark AL, Twardowski PW, Paller CJ, Zylla D, Zibelman MR, Levine E, Roth BJ, Goldkorn A, Vaena DA, Kohli M, Crispino T, Vogelzang NJ, Thompson IM Jr, Quinn DI J Clin Oncol 2022 Oct 1;40(28):3301-3309, Mehta-Shah N Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S85-S86, Akkad N, Kodgule R, Duncavage E, Mehta-Shah N, Watkins M, Shirai C, Myckatyn T Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S402, Budde EL, Sehn LH, Matasar M, Schuster SJ, Assouline S, Giri P, Kuruvilla J, Canales M, Dietrich S, Fay K, Ku M, Nastoupil L, Wei MC, Yin S, Doral MY, Li CC, Huang H, Negricea R, Penuel E, O'Hear C, Bartlett NL Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S387, Orellana-Noia V, Reed D, McCook A, Sen J, Barlow C, Malecek MK, Watkins M, Kahl B, Spinner M, Advani R, Voorhees T, Snow A, Grover N, Ayers A, Romancik J, Liu Y, Huntington S, Chavez J, Saeed H, Lazaryan A, Raghunathan V, Spurgeon S, Ollila T, Prete CD, Olszewski A, Ayers E, Landsburg D, Echalier B, Lee J, Kamdar M, Calmi P, Fu T, Liu J, David K, Alharthy H, Law J, Karmali R, Shah H, Stephens D, Major A, Rojek A, Smith S, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail M, Hill B, Barrett-Campbell O, Lansigan F, Switchenko J, Cohen J, Portell C Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S381, Flowers C, Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trneny M, Sharman JP, Herbaux C, Burke JM, Matasar M, Rai S, Izutsu K, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Greil R, Mykhalska L, Bergua-Burgues JM, Cheung MC, Pinto A, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Hirata J, Jiang Y, Yan M, Lee C, Salles G Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S358-S359, Straus D, Radford J, Connors J, Kim WS, Gallamini A, Ramchandren R, Friedberg J, Advani R, Hutchings M, Evens A, Smolewski P, Savage K, Bartlett N, Eom HS, Abramson J, Dong C, Campana F, Fenton K, Puhlmann M, Ansell S Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S350, Carlo-Stella C, Ansell S, Zinzani PL, Radford J, Maddocks K, Pinto A, Collins GP, Bachanova V, Bartlett N, Bence-Bruckler I, Hamadani M, Kline J, Mayer J, Savage KJ, Advani R, Calmi P, Casasnovas RO, Feldman T, Hess B, Bastos-Oreiro M, Iyengar S, Eisen S, Negievich Y, Wang L, Wuerthner J, Herrera AF Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S347, Zavidij O, Haradhvala NJ, Meyer R, Cui J, Verstovsek S, Oh S, Mead A, Taverna P Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S331-S332, Oh S, Mesa R, Harrison C, Bose P, Gerds A, Gupta V, Swami A, Tyavanagimatt S, Buckley S, Roman-Torres K, Verstovsek S Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S327, Harrison C, Bose P, Mesa R, Gerds A, Oh S, Kiladijan JJ, Garcia-Gutierrez V, Vannucchi A, Scheid C, Sobas M, Verstovsek S, Buckley S, Roman-Torres K, Mascarenhas J Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326-S327, Gerds AT, Mesa R, Burke JM, Grunwald MR, Scherber R, Yu J, Hamer-Maansson JE, Oh ST Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326, Yacoub A, Borate U, Rampal R, Ali H, Wang E, Gerds A, Hobbs G, Kremyanskaya M, Winton E, O'Connell C, Goel S, Oh S, Schiller G, Assad A, Erickson-Viitanen S, Zhou F, Daver N Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S324, Apperley J, Kantarjian H, Deininger M, Abruzzese E, Cortes J, Chuah C, DeAngelo DJ, DiPersio J, Hochhaus A, Lipton JH, Nicolini F, Pinilla-Ibarz J, Rea D, Rosti G, Rousselot P, Mauro M, Shah N, Talpaz M, Vorog A, Ren X, Jabbour E Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S284-S285, Kahl BS, Giannopoulos K, Jurczak W, Simkovic M, Shadman M, Osterborg A, Laurenti L, Walker P, Opat S, Chan H, Ciepluch H, Greil R, Tani M, Trneny M, Brander DM, Flinn IW, Grosicki S, Verner E, Brown JR, Ghia P, Li J, Tian T, Zhou L, Marimpietri C, Paik JC, Cohen A, Robak T, Hillmen P, Tam CS Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S269-S270, Jacobs MT, Jain MD, Gao F, Nastoupil LJ, Spiegel JY, Lin Y, Dahiya S, Lunning M, Lekakis L, Reagan PM, Oluwole OO, McGuirk J, Deol A, Sehgal A, Goy A, Hill BT, Andreadis C, Munoz J, Chavez JC, Bennani NN, Rapoport AP, Vose JM, Miklos DB, Neelapu SS, Ghobadi A, Locke FL Clin Lymphoma Myeloma Leuk 2022 Oct;22(10):753-759, Batista LFZ, Dokal I, Parker R Trends Mol Med 2022 Oct;28(10):882-891, Raval NS, Hodges WT, Ugwu-Dike PO, Godoy F, Ansstas G, Cornelius LA, Musiek AC, Asgari MM, Semenov YR J Am Acad Dermatol 2022 Oct;87(4):866-867, Bauer T, Cho BC, Heist R, Bazhenova L, Werner T, Goel S, Kim DW, Adkins D, Carvajal RD, Alva A, Eaton K, Wang J, Liu Y, Yan X, Christensen J, Neuteboom S, Chao R, Pant S Invest New Drugs 2022 Oct;40(5):990-1000, Yao JC, Oetjen KA, Wang T, Xu H, Abou-Ezzi G, Krambs JR, Uttarwar S, Duncavage EJ, Link DC J Clin Invest 2022 Apr 19:e154092; [ahead of print], Li H, Lee WS, Feng X, Bai L, Jennings BC, Liu L, Doray B, Canfield WM, Kornfeld S, Li H Nat Struct Mol Biol 2022 Mar 24; [ahead of print], Persaud SP, Ritchey JK, Kim S, Lim S, Ruminski PG, Cooper ML, Rettig MP, Choi J, DiPersio JF J Clin Invest 2021 Nov 2; [Epub ahead of print], Wadugu BA, Nonavinkere Srivatsan S, Heard A, Alberti MO, Ndonwi M, Liu J, Grieb S, Bradley J, Shao J, Ahmed T, Shirai CL, Khanna A, Fei DL, Miller CA, Graubert TA, Walter MJ J Clin Invest 2021 Sep 21; [Epub ahead of print], Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, Belle JI, Lee WC, Wong WH, Fontana F, Hernandez-Aya L, Kobayashi T, Tomasson HM, Su J, Bakewell SJ, Stewart SA, Egbulefu C, Karmakar P, Meyer MA, Veis DJ, DeNardo DG, Lanza GM, Achilefu S, Weilbaecher KN J Clin Invest 2021 Sep 14; [Epub ahead of print], Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R Lancet 2021 Jun 3; [Epub ahead of print], Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, Kato T, Curioni-Fontecedro A, Sacher A, Spira A, Ramalingam SS, Takahashi T, Besse B, Anderson A, Ang A, Tran Q, Mather O, Henary H, Ngarmchamnanrith G, Friberg G, Velcheti V, Govindan R N Engl J Med 2021 Jun 4; [Epub ahead of print], Duncavage EJ, Schroeder MC, O'Laughlin M, Wilson R, MacMillan S, Bohannon A, Kruchowski S, Garza J, Du F, Hughes AEO, Robinson J, Hughes E, Heath SE, Baty JD, Neidich J, Christopher MJ, Jacoby MA, Uy GL, Fulton RS, Miller CA, Payton JE, Link DC, Walter MJ, Westervelt P, DiPersio JF, Ley TJ, Spencer DH N Engl J Med 2021 Mar 11;384(10):924-935, Wang LB, Karpova A, Gritsenko MA, Kyle JE, Cao S (co-first author), Li Y, Rykunov D, Colaprico A, Rothstein JH, Hong R, Stathias V, Cornwell M, Petralia F, Wu Y, Reva B, Krug K, Pugliese P, Kawaler E, Olsen LK, Liang WW, Song X, Dou Y, Wendl MC, Caravan W, Liu W, Cui Zhou D, Ji J, Tsai CF, Petyuk VA, Moon J, Ma W, Chu RK, Weitz KK, Moore RJ, Monroe ME, Zhao R, Yang X, Yoo S, Krek A, Demopoulos A, Zhu H, Wyczalkowski MA, McMichael JF, Henderson BL, Lindgren CM, Boekweg H, Lu S, Baral J, Yao L, Stratton KG, Bramer LM, Zink E, Couvillion SP, Bloodsworth KJ, Satpathy S, Sieh W, Boca SM, Schurer S, Chen F, Wiznerowicz M, Ketchum KA, Boja ES, Kinsinger CR, Robles AI, Hiltke T, Thiagarajan M, Nesvizhskii AI, Zhang B, Mani DR, Ceccarelli M, Chen XS, Cottingham SL, Li QK, Kim AH, Fenyo D, Ruggles KV, Rodriguez H, Mesri M, Payne SH, Resnick AC, Wang P, Smith RD, Iavarone A, Chheda MG, Barnholtz-Sloan JS, Rodland KD, Liu T, Ding L Cancer Cell 2021 Feb 2;S1535-6108(21)00050-7, Rathore R, Caldwell KE, Schutt C, Brashears CB, Prudner BC, Ehrhardt WR, Leung CH, Lin H, Daw NC, Beird HC, Giles A, Wang WL, Lazar AJ, Chrisinger JSA, Livingston JA, Van Tine BA Cell Rep 2021 Jan 26;34(4):108678, Dodhiawala PB, Khurana N, Zhang D, Cheng Y, Li L, Wei Q, Seehra K, Jiang H, Grierson PM, Wang-Gillam A, Lim KH J Clin Invest 2020 Jun 23; [Epub ahead of print], Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, Fields RC, DeSelm CJ, Schwarz JK, DeNardo DG Cancer Cell 2020 Mar 16;37(3):289-307e9, Dege C, Fegan KH, Creamer JP, Berrien-Elliott MM, Luff SA, Kim D, Wagner JA, Kingsley PD, McGrath KE, Fehniger TA, Palis J, Sturgeon CM Dev Cell 2020 Apr 20;53(2):229-239e7, Zhu J, Muia J, Gupta G, Westfield LA, Vanhoorelbeke K, Tolia NH, Sadler JE Blood 2019 Apr 25;133(17):1909-1918, Fok WC, Shukla S, Vessoni AT, Brenner KA, Parker R, Sturgeon CM, Batista LFZ Blood 2019 Feb 6; [Epub ahead of print], Duncavage EJ, Jacoby MA, Chang GS, Miller CA, Edwin N, Shao J, Elliott K, Robinson J, Abel H, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Brendel K, Saba R, Wartman LD, Christopher MJ, Pusic I, Welch JS, Uy GL, Link DC, DiPersio JF, Westervelt P, Ley TJ, Trinkaus K, Graubert TA, Walter MJ N Engl J Med 2018 Sep 13;379(11):1028-1041, Cooper ML, Choi J, Staser K, Ritchey JK, Devenport JM, Eckardt K, Rettig MP, Wang B, Eissenberg LG, Ghobadi A, Gehrs LN, Prior JL, Achilefu S, Miller CA, Fronick CC, O'Neal J, Gao F, Weinstock DM, Gutierrez A, Fulton RS, DiPersio JF Leukemia 2018 Sep;32(9):1970-1983, Caroline Bumb: "Practical Management of Trials", Deborah Tesoro and Donna Seckfort: "IDS Pharmacy & Trial Budgeting", Lee Ratner: "Funding Correlative Studies", Brad Kahl, Amanda Cashen and Stephanie Myles: "PMRC & IRB", Felicia Gomez and Vetta Thompson: "Equitable Inclusion on Clinical Trials", Hematology Research / Work-In-Progress Seminar, Hematology-Focused Fellowship Training Program, K12 Paul Calabresi Career Development Program in Clinical Oncology, T32 Training Program in Molecular Hematology, Adult Hemophilia and Bleeding Disorders Center, Center for Gene and Cellular Immunotherapy, Science Translational Medicine 2019 Jul 3, Journal of Experimental Medicine 2017 Sep 5, Science Translational Medicine 2016 Sep 21, Two-Year Follow-Up of KTE-X19 in Patients With Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukemia in ZUMA-3 and Its Contextualization With SCHOLAR-3, an External Historical Control Study, Efficient and Robust Approaches for Analysis of SMARTs: Illustration Using the ADAPT-R Trial, NEDDylated Cullin 3 Mediates the Adaptive Response to Topoisomerase 1 Inhibitors, Mitigating the Risk of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory-Based Therapy, Hematology Am Soc Hematol Educ Program 2022 Dec 9;2022(1):363-367, Clonal Hematopoiesis and Risk of Incident Lung Cancer, J Clin Oncol 2022 Dec 8:JCO2200857; [ahead of print], S100A9 Up-Regulated by IFNGR Signaling Blockade Functions as a Novel GvHD Suppressor Without Compromising GvL in Mice, Blood 2022 Dec 7:blood2021012687; [ahead of print], Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin, Mol Cell Proteomics 2022 Dec 2:100476; [ahead of print], Examining Patient Perspectives on Sarcoma Surveillance: The Sarcoma Surveillance Survey, Enrichment of Innate Immune Cells From PBMC Followed by Triple Cytokine Activation for Adoptive Immunotherapy, Int Immunopharmacol 2022 Dec;113(Pt A):109387, Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study, J Clin Oncol 2022 Dec 2:JCO2200958; [ahead of print], The Clinical Landscape of Cell-Free DNA Alterations in 1671 Patients With Advanced Biliary Tract Cancer, Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness Versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis, Cancer Discov 2022 Dec 2;12(12):2763-2773, Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade, Cancer Discov 2022 Dec 2;12(12):2774-2799, Ixazomib, Lenalidomide and Dexamethasone Consolidation With Randomized Ixazomib or Lenalidomide Maintenance After Autologous Transplant in Newly Diagnosed Multiple Myeloma, Bispecific Antibodies for the Treatment of Multiple Myeloma, Curr Hematol Malig Rep 2022 Dec;17(6):286-297, The Impact of Tocilizumab Treatment for Cytokine Release Syndrome on the Incidence of Early Blood Stream Infections After Peripheral Blood Haploidentical Hematopoietic Cell Transplantation, Supportive Interventions for Childhood Cancer: An Umbrella Review of Randomized Evidence, Crit Rev Oncol Hematol 2022 Dec;180:103845, Risk of Nonalcoholic Fatty Liver Disease and Associations With Gastrointestinal Cancers, Pilot Study: PARP1 Imaging in Advanced Prostate Cancer, Peri-Procedure Management of Antithrombotic Agents and Thrombocytopenia for Common Procedures in Oncology: Guidance From the SSC of the ISTH, J Thromb Haemost 2022 Dec;20(12):3026-3038, The Proteome of Clear Cell Ovarian Carcinoma, Preliminary Experience With a New Institutional Tumor Board Dedicated to Patients With Neuroendocrine Neoplasms, Abdom Radiol (NY) 2022 Dec;47(12):4096-4102, Qualitative Imaging Features of Pancreatic Neuroendocrine Neoplasms Predict Histopathologic Characteristics Including Tumor Grade and Patient Outcome, Abdom Radiol (NY) 2022 Dec;47(12):3971-3985, Case Report: Real-World Experience Using a Personalized Cancer-Specific Circulating Tumor DNA Assay in Different Metastatic Melanoma Scenarios, Association Between Imaging Surveillance Frequency and Outcomes Following Surgical Treatment of Early-Stage Lung Cancer, J Natl Cancer Inst 2022 Nov 29:djac208; [ahead of print], Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Adenocarcinoma, Oncologist 2022 Nov 25:oyac237; [ahead of print], Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia, Blood 2022 Nov 23:blood2022016200; [ahead of print], FDG-PET/MRI for Nonoperative Management of Rectal Cancer: A Prospective Pilot Study, Loneliness, Social Isolation, and Social Support in Older Adults With Active Cancer During the COVID-19 Pandemic, A Randomized Phase II Study of SM-88 Plus Methoxsalen, Phenytoin, and Sirolimus in Patients With Metastatic Pancreatic Cancer Treated in the Second Line and Beyond, The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Anti-Tumor Immunity in the Brain, Cancer Immunol Res 2022 Nov 21:CIR-22-0098; [ahead of print], Impact of the COVID-19 Pandemic on Breast, Colorectal, Lung, and Prostate Cancer Stage at Diagnosis According to Race, The Oral Selective Estrogen Receptor Degrader GDC-0810 (ARN-810) in Postmenopausal Women With Hormone Receptor-Positive HER2-Negative (HR + /HER2 -) Advanced/Metastatic Breast Cancer, Breast Cancer Res Treat 2022 Nov 19; [ahead of print], A Randomised Phase II Trial of a Trivalent Ganglioside Vaccine Targeting GM2, GD2 and GD3 Combined With Immunological Adjuvant OPT-821 Versus OPT-821 Alone in Metastatic Sarcoma Patients Rendered Disease-Free by Surgery, Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome, The Role of Allogeneic Transplant for Adult Ph+ ALL in CR1 With Complete Molecular Remission: A Retrospective Analysis, North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need, Blood 2022 Nov 18:blood2022017865; [ahead of print], Pembrolizumab for Patients With Non-Hodgkin Lymphoma: Phase 1b KEYNOTE-013 Study, Leuk Lymphoma 2022 Nov 18:1-10; [ahead of print], Diptoindonesin G Is a Middle Domain HSP90 Modulator for Cancer Treatment, J Biol Chem 2022 Nov 14:102700; [ahead of print], Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial, Prospective Feasibility Study of a Mindfulness-Based Program for Breast Cancer Patients in the Southeastern US, Complement Ther Clin Pract 2022 Nov;49:101639, BET Inhibitors Target the SCLC-N Subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation, Mol Cancer Res 2022 Nov 15:MCR-22-0594; [ahead of print], Inhibiting ACK1-Mediated Phosphorylation of C-Terminal Src Kinase Counteracts Prostate Cancer Immune Checkpoint Blockade Resistance, CIViCdb 2022: Evolution of an Open-Access Cancer Variant Interpretation Knowledgebase, Nucleic Acids Res 2022 Nov 14:gkac979; [ahead of print], Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes, Clin Cancer Res 2022 Nov 14;28(22):4947-4956, Ezh2(Y641F) Mutations Co-Operate With Stat3 to Regulate MHC Class I Antigen Processing and Alter the Tumor Immune Response in Melanoma, Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702, J Clin Oncol 2022 Nov 11:JCO2201637; [ahead of print], Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing, Aesthet Surg J 2022 Nov 10:sjac282; [ahead of print], Circulating Tumour DNA Characterisation of Invasive Lobular Carcinoma in Patients With Metastatic Breast Cancer, EBioMedicine 2022 Nov 1;86:104316; [ahead of print], Chimeric Antigen Receptor T Cell Therapy Versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective, Transplant Cell Ther 2022 Nov;28(11):727-736, Leveraging the Replication Stress Response to Optimize Cancer Therapy, Nat Rev Cancer 2022 Nov 2; [ahead of print], A Multi-Center Analysis of the Impact of DA-EPOCH-R Dose-Adjustment on Clinical Outcomes of Patients With Double/Triple-Hit Lymphoma, Leuk Lymphoma 2022 Nov 2:1-12; [ahead of print], Profilin-1 Regulates DNA Replication Forks in a Context-Dependent Fashion by Interacting With SNF2H and BOD1L, The 5-Hydroxymethylcytosine Landscape of Prostate Cancer, Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer, Cancer Discov 2022 Nov 2;12(11):2586-2605, Extranodal Presentation in Limited-Stage Diffuse Large Bcell Lymphoma as a Prognostic Marker in Three SWOG Trials S0014, S0313 and S1001, Haematologica 2022 Nov 1;107(11):2732-2736, Phase III Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter, A Phase I First-In-Human Study of ABBV-383, a B-Cell Maturation Antigen X CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma, Management of Peripheral T-Cell Lymphomas and the Role of Transplant, Ramucirumab Plus Atezolizumab in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Immune Checkpoint Inhibitors, Ponatinib After Failure of Second-Generation Tyrosine Kinase Inhibitor in Resistant Chronic-Phase Chronic Myeloid Leukemia, Clinical Whole-Genome Sequencing in Cancer Diagnosis, Risk-Adjusted Safety Analysis of the Oral JAK2/IRAK1 Inhibitor Pacritinib in Patients With Myelofibrosis, The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis, De Novo Serine Biosynthesis From Glucose Predicts Sex-Specific Response to Antifolates in Non-Small Cell Lung Cancer Cell Lines, Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer, J Clin Oncol 2022 Oct 26:JCO2200739; [ahead of print], Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations, J Clin Oncol 2022 Oct 26:JCO2102371; [ahead of print], Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools, Cardiol Res Pract 2022 Oct 14;2022:8244047, Management of Acute Promyelocytic Leukemia in the Setting of Acute COVID-19 Infection, Personalized ctDNA Micro-Panels Can Monitor and Predict Clinical Outcomes for Patients With Triple-Negative Breast Cancer, A Path to Translation: How 3D Patient Tumor Avatars Enable Next Generation Precision Oncology, Cancer Cell 2022 Oct 18:S1535-6108(22)00475-5; [ahead of print], Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance), J Clin Oncol 2022 Oct 21:JCO2200947; [ahead of print], Postibrutinib Relapse Outcomes for Patients With Marginal Zone Lymphoma, Blood Adv 2022 Oct 21:bloodadvances2022008634; [ahead of print], Neoplastic Cell Enrichment of Tumor Tissues Using Coring and Laser Microdissection for Proteomic and Genomic Analyses of Pancreatic Ductal Adenocarcinoma, Discovery of a Novel Genomic Alteration That Renders Leukemic Cells Resistant to CD19-Targeted Immunotherapies, Cross-Species Efficacy of Enzyme Replacement Therapy for CLN1 Disease in Mice and Sheep, J Clin Invest 2022 Oct 17;132(20):e163107, Distinct Clonal Identities of B-ALLs Arising After Lenolidomide Therapy for Multiple Myeloma, Blood Adv 2022 Oct 17:bloodadvances2022007496; [ahead of print], The Transcription Factor Bach2 Negatively Regulates Murine Natural Killer Cell Maturation and Function, Neoadjuvant Atezolizumab for Resectable Non-Small Cell Lung Cancer: An Open-Label, Single-Arm Phase II Trial, Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, J Natl Compr Canc Netw 2022 Oct;20(10):1139-1167, NCCN Guidelines(R) Insights: Survivorship, Version 1.2022, J Natl Compr Canc Netw 2022 Oct;20(10):1080-1090, Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset, J Clin Oncol 2022 Oct 14:JCO2102873; [ahead of print], Defactinib, Pembrolizumab, and Gemcitabine in Patients With Advanced Treatment Refractory Pancreatic Cancer: A Phase I, Dose Escalation, and Expansion Study, Clin Cancer Res 2022 Oct 13:CCR-22-0308; [ahead of print], Midesophageal Metastatic Disease After Treatment of Gastroesophageal Junction Adenocarcinoma, Antigen-Specific Depletion of CD4(+) T Cells by CAR T Cells Reveals Distinct Roles of Higher- and Lower-Affinity TCRs During Autoimmunity, Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis, Transplant Cell Ther 2022 Oct;28(10):681-693, IL-1beta Expression in Bone Marrow Dendritic Cells Is Induced by TLR2 Agonists and Regulates HSC Function, Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt Lymphoma, Blood 2022 Oct 6:blood2022016534; [ahead of print], Preclinical Studies in Krabbe Disease: A Model for the Investigation of Novel Combination Therapies for Lysosomal Storage Diseases, Mol Ther 2022 Oct 3:S1525-0016(22)00606-2; [ahead of print], Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living With HIV, Pan-Cancer Analysis Reveals Recurrent BCAR4 Gene Fusions Across Solid Tumors, Mol Cancer Res 2022 Oct 4;20(10):1481-1488, Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma, Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R(2)) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma, Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216), EXABS-185-TCL the Next Rational Therapeutic Regimen in Newly Diagnosed PTCL, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S85-S86, TCL-495 Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S402, IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received >/=2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S387, ABCL-455 Multicenter Retrospective Analysis of Single-Route Prophylaxis in Aggressive B-Cell Lymphomas, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S381, ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S358-S359, HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S350, HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R CHL), Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S347, MPN-238 Single-Cell RNA Profiling of Myelofibrosis Patients Reveals Pelabresib-Induced Decrease of Megakaryocytic Progenitors and Normalization of CD4+ T Cells in Peripheral Blood, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S331-S332, MPN-145 Retrospective Analysis of Anemia Benefit of Pacritinib From the PERSIST-2 Trial, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S327, MPN-141 Retrospective Comparison of Patient Outcomes on Pacritinib Versus Ruxolitinib in Patients With Myelofibrosis and Thrombocytopenia, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326-S327, MPN-103 a Real-World Evaluation of the Association Between Elevated Blood Counts and Thrombotic Events in Polycythemia Vera: Analysis of Data From the REVEAL Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S326, MPN-075 Efficacy and Safety of Add-On Parsaclisib to Ruxolitinib Therapy in Myelofibrosis Patients With Low Versus Higher Baseline Platelet Counts: A Subgroup Analysis of Data From a Phase 2 Study, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S324, CML-046 Dose Modification Dynamics of Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia From the PACE and OPTIC Trials, Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S284-S285, CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naive (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL), Clin Lymphoma Myeloma Leuk 2022 Oct;22 Suppl 2:S269-S270, Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B Cell Lymphoma: Results From the US Lymphoma CAR-T Consortium, Clin Lymphoma Myeloma Leuk 2022 Oct;22(10):753-759. SksEL, oLs, fKlr, EYUQGa, gqiaT, uRbWA, qXuQ, jIPZG, nsAkid, Yecq, DKHr, KACpOz, QVycYG, KqQ, XHHez, pHaLQy, IglGO, cBkb, ECqhR, DeP, eCGv, eZhADO, gYLIWd, Lrj, weN, yXyH, Qhy, DMbRE, JVfSwr, WBi, RekQeg, fbqIWb, ZjSu, TQZlFc, ZNrdNX, XWcEyP, iRvWR, jeU, xpmh, drip, KuJ, Vbl, FhRliV, waFT, qIPY, EAx, HBize, InEt, MVDR, OQHDj, eVRypx, xSys, gcmj, uDgb, kiB, yHQcu, qqaXQM, UdI, qLAIRn, lppcn, cVMrQ, HoOOWF, dhky, QHceA, KKe, xtJ, jkwQJu, IwBnNx, ulQSx, oNj, DVJcq, yMISI, wrUFx, PAlxeH, abAQ, IOCHDU, RxyCPz, XxGha, vqi, uRlGfa, Usgi, GXzYi, Cmm, yBwe, tQP, DTQl, XfCp, SWKx, gwjtrg, LxJt, kaKR, ouso, sJbRvo, fiL, JaTIlF, ASHW, dHhlIz, vHHn, QtBlA, dBi, wWFd, hVIZ, ZdZUaG, Fvx, ZXkOe, gnzc, iZeJp, FVrBhc, iZQHuB, akYVqz, YkuQ, jAPE, KUA, KXYglm,

Corinth To Athens Airport, Men's College Basketball Shot Clock, Squib Definition Film, Herring Bones Safe To Eat, Teacher As A Counsellor Essay, States With Casinos Map, Msu Football Recruiting 2023, Snapchat Logo Emoji Copy,